Program for all days

Better Kidney Health
The Interconnected Kidney
The Kidney Losing Function
The Smart Kidney
Plenary Sessions
Pre-congress Courses
Special Sessions
Spotlight Sessions
Industry Symposia
Global Kidney Policy Forum
Welcome Reception
Topical Networking
Poster Sessions

Friday, February 7, 2025

Time Session
9:45 a.m.
11:15 a.m.
GeorgiAbraham Chair abraham_georgi@yahoo.comMGM Healthcare, Chennai, IndiaIndia
KriangTungsanga Chair kriangtungsanga@hotmail.comDepartment of Medicine, Faculty of Medicine, Chulalongkorn UnviersityThailand
  • Renal Complications of Novel Cancer Therapies: Practical Insights
    AnushreeShirali Speaker
  • Immune Checkpoint Inhibitors and AKI
    MitchellRosner Speaker Univeristy of Virginia HealthUnited States
  • Electrolyte Abnormalities in the Cancer Patient
    JolantaMalyszko Speaker Medical University of Warsaw, PolandPoland
  • Opening an Onconephrology Clinic - What Should You Be Aware of?
    KenarJhaveri Speaker United States
  • Q&A
Amaltas A Hall B101A
IfeomaUlasi Chair College of Medicine, University of NigeriaNigeria
Sanjib KumarSharma Chair Nepal
ShubharthiKar Chair shubharthi@gmail.comHabiganj Medical College,BangladeshBangladesh
  • Detecting and Monitoring CKD Progression
    ElkeSchaeffner Speaker Charité Universitätsmedizin Berlin, GermanyGermany
  • How to Slow and Prevent Kidney and Cardiovascular Complications
    Magdalena Madero Speaker Chief of Nephrology, Instituto Nacional de CardiolMexico
  • Managing Complex CKD Cases With Multiple Comorbidities
    NatashaMcIntyre Speaker Canada
  • Quality of Life in CKD: The Role of Drug Stewardship and Symptom Management
    TeerawatThanachayanont Speaker Bhumirajanagarindra Kidney Institute HospitalThailand
  • Q&A
Amaltas B Hall B101A
PrabirRoy-Chaudhury Chair prabir@email.unc.eduUniversity of North Carolina and Salisbury VAMCUnited States
Raja Ramachandran Chair Associate ProfessorIndia
ReikoInagi Chair The University of Tokyo Graduate School of MedicineJapan
  • Genetic Variants in Kidney Diseases
    TomokoHorinouchi Speaker Department of Pediatrics, Kobe University Graduate School of MedicineJapan
  • Molecular Data and Genetic Discoveries in Kidney Diseases
    KrzysztofKiryluk Speaker Columbia UniversityUnited States
  • Trends in Diagnosing Genetic Kidney Diseases
    EiseiSohara Speaker
  • Metabolism of Genetic Kidney Diseases (Pathogenic Podocyte Lipid Metabolism of Alport Syndrome)
    AlessiaFornoni Speaker United States
  • Q&A
Auditorium Brahmkamal Hall
SabineKaram Chair sabinejkaram@gmail.comUniversity of MinnesotaUnited States
SourabhSharma Chair Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, IndiaIndia
  • Best Abstract Winner - Basic Science
  • Best Abstract Winner - Clinical Research
  • Q and A
  • Everything You Ever Wanted to Know About Tropical Infections and the Kidney
    MythriShankar Speaker Institute of NephrourologyIndia
  • Challenges in the Tropics: When CKDu Becomes Less Unknown
    ErangaWijewickrama Speaker Faculty of Medicine, University of ColomboSri Lanka
  • Roundtable Discussion
    BiancaDavidson Speaker Groote Schuur Hospital, University of Cape TownSouth Africa
    ErangaWijewickrama Speaker Faculty of Medicine, University of ColomboSri Lanka
    MythriShankar Speaker Institute of NephrourologyIndia
    SourabhSharma Speaker Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, IndiaIndia
    VivekKumar Speaker Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaIndia
Champa Hall 304
UttaraDas Chair uttaradas806@gmail.comIndia
  • What Should a Clinician Know About CKD-MBD in 2025?
    HanneJoergensen Speaker Aarhus UniversityDenmark
  • CKD-MBD in Children and Young Adults: What's the Difference?
    SukanyaGovindan Speaker Mehta Children's Hospitals and MGM healthcare, Chennai, India
  • Progress in CKD-driven Vascular Calcification: From Bench to Bedside
    MarcVervloet Speaker Radboud University Medical center, The Netherlands
  • How to Use Serum Biomarkers for Optimal Management of CKD-MBD
    SandroMazzaferro Speaker Sapienza University of Rome, ItalyItaly
  • Q&A
Gulmohar Hall 302
Measuring Healthcare Transition Readiness to Adult-Focused Care Among Solid Organ Pediatric Transplant Recipients
Kesar Hall 202
  • Artificial and Human Intelligence Work Best Together: Pathomics in 2025
    LauraBarisoni Speaker Duke University
  • Mapping Molecular Data Sets on Clinical Profiles
    VijiNair Speaker University of MichiganUnited States
  • The Kidney Precision Medicine Project (KPMP) Kidney Tissue Atlas: Latest Developments
    SanjayJain Speaker
  • Introduction to the Hands-on Big Data Lab
    HeatherAscani Speaker United States
    NikkiBonevich Speaker United States
    VijiNair Speaker University of MichiganUnited States
Kumudini Hall 301
GermaineWong Chair University of SydneyAustralia
SundararamanSwaminathan Chair swami@iisc.ac.in
  • People, the Planet, and Nephrology - the Impact of Environmental Change on Kidney Health
    Giorgina BarbaraPiccoli Speaker Centre Hospitalier Le MansFrance
  • How to Develop a Roadmap for Environmentally Sustainable Kidney Care
    KatherineBarraclough Speaker Australia
  • How Do I Make My Dialysis Unit More Environment-friendly?
    TanujLamech Speaker
  • What Will Kidney Care Look Like 25 Years From Now? The Role of Future Generations
    Winston Wing ShingFung Speaker Prince of Wales Hospital, Hong KongHong Kong, China
  • Q&A
Neelkamal Hall 305
VinayRathore Chair vinayrathoredm@aiimsraipur.edu.inIndia
  • Outcomes From the ISN Haemolytic Uraemic Syndromes Forum: A Comprehensive Review
    DavidKavanagh Speaker National Renal Complement Therapeutics Centre United Kingdom
  • Differential Diagnosis and Treatment of TMAs in Pregnancy
    ShilpanjaliJesudason Speaker Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
  • Antiphospholipid Syndrome in Pregnancy
  • aHUS in Paediatric Populations
    Alison Lap-Tak Ma Speaker Hong Kong, China
  • Q&A
Parijat Hall 201
11:45 a.m.
12:45 p.m.
  • Mathematical Modelling of Diseases, Focus on Kidney Disease. Stewart Cameron Lecture
    AnitaLayton Speaker University of Waterloo
  • Q and A
  • Acceptance Speech: Roscoe Robinson Award
    ShilpanjaliJesudason Speaker Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
Auditorium Brahmkamal Hall
1 p.m.
2 p.m.
Industry Symposium
Amaltas A Hall B101A
2:15 p.m.
3:45 p.m.
Christoph Wanner Chair wanner_c@ukw.deGermany
SishirGang Chair sishirgang@hotmail.comIndia
  • Making the Perfect Pig Kidney
  • The First Pig to Human Transplant
    LeonardoRiella Speaker United States
  • Infectious Challenges in Xenotransplant
    AtulHumar Speaker University of TorontoCanada
  • Ethical Challenges of Xenotransplantation
    DominiqueMartin Speaker Deakin UniversityAustralia
  • Q&A
Amaltas A Hall B101A
Parminder KaurJudge Chair parminder.judge@ndph.ox.ac.ukUniversity of Oxford, UKUnited Kingdom
  • Cardiovascular-Kidney-Metabolic Syndrome: What Does it Mean?
    KatherineTuttle Speaker University of Washington School of Medicine, Division of NephrologyUnited States
  • GLP-1 RA in Kidney Disease: Beyond T2DM Control
    BeatrizFernandez-Fernandez Speaker Hospital Universitario Fundación Jimenez Díaz Spain
  • New Frontiers in CKD Therapy: Endothelin Receptor Antagonists
    Maria JoséSoler Romeo Speaker Hospital del Vall d´HebronSpain
  • Myocardial Infarction in Kidney Disease - What Should a Nephrologist Know?
  • Q&A
Amaltas B Hall B101A
AndreaViecelli Chair andrea.viecelli@health.qld.gov.auUniversity of QueenslandAustralia
  • Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE)—Baseline Characteristic
    RajivAgarwal Oral Abstract Presenter United States
  • Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial
    KatherineTuttle Oral Abstract Presenter University of Washington School of Medicine, Division of NephrologyUnited States
  • Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
    BradRovin Oral Abstract Presenter The Ohio State UniversityUnited States
Auditorium Brahmkamal Hall
AmitGupta Chair dramitguptanephropgi@gmail.comIndia
RobertoPecoits Filho Chair Arbor Research Collaborative for HealthUnited States
  • PDOPPS: Where Are We 10 Years Later?
    JeffreyPerl Speaker St. Michael's Hospital Canada
  • Kidney Health for Women on Peritoneal Dialysis: Insights from PDOPPS
    EdwinaBrown Speaker Imperial College Healthcare NHS TrustUnited Kingdom
  • Was the PD-First Policy in Thailand Justified? Insights From the PDOPPS
    TalerngsakKanjanabuch Speaker Faculty of Medicine, Chulalongkorn UniversityThailand
  • Improving PD Use and Outcomes in Low and Middle-income Countries - Is Automated Peritoneal Dialysis the Answer? Yes
    JeffreyPerl Speaker St. Michael's Hospital Canada
  • Improving PD Use and Outcomes in Low and Middle-income Countries - Is Automated Peritoneal Dialysis the Answer? No
    RashaDarwish Speaker Kasr Aleiny medical school , Cairo UniversityEgypt
  • Q&A/Panel Discussion
Gulmohar Hall 302
Prof (Dr ) SanjeevGulati Chair sgulati2002@gmail.comIndia
  • Sustainable Community Approaches to Early CKD Detection
    RonaldGansevoort Speaker Dept. Nephrology, University Medical Center Groningen
  • Kidney Disease Treatment Gaps Worldwide - Where Are the Solutions?
    AdeeraLevin Speaker Canada
  • The Promise of Emerging Therapies in Reducing the Global Kidney Disease Burden
    DavidWheeler Speaker University College LondonUnited Kingdom
  • Co-opting Patients as Partners in Kidney Care: How Do We Do It?
    ShilpanjaliJesudason Speaker Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
  • Co-opting Patients as Partners in Kidney Care: How Do We Do It?
    ShyamsundarMuthuramalingam Speaker Central Adelaide Local Health Network Australia
  • Q&A
Kesar Hall 202
JonathanBarratt Chair University of Leicester, Leicester, UKUnited Kingdom
SradhaKotwal Chair skotwal@georgeinstitute.org.auThe George Institute for Global HealthAustralia
TukaramJamale Chair tukaramjamale@yahoo.co.inProfessor and Head, Department of Nephrology, Seth GS Medical College and KEM Hospital, Mumbai IndiaIndia
  • New Innovations and Best Practices for Rare Kidney Disease
    JonathanBarratt Speaker University of Leicester, Leicester, UKUnited Kingdom
  • How Can the CureGN Help Us Better Understand Rare Kidney Disease?
    LauraMariani Speaker University of MichiganUnited States
  • Insights From Rare Kidney Disease Registries on Living With RKDs
    DanielGale Speaker
  • Living With Rare Kidney Disease in Africa: Experiences and Challenges
    IfeomaUlasi Speaker College of Medicine, University of NigeriaNigeria
  • Q&A
Kumudini Hall 301
Arup Ratan Dutta Chair duttascomplex@gmail.comIndia
CarmenTzanno Branco Martins Chair tzanno@gmail.comSLANH, ISNBrazil
TusharVachharajani Chair tvachh@gmail.comJohn D. Dingell Veterans Affairs Medical Center / Wayne State University School of MedicineUnited States
  • Multi-organ POCUS in AKI
    AbhilashKortala Speaker
  • Changing Paradigms in Dialysis Vascular Access - What Should the Current Day Nephrologist Know?
    VandanaNiyyar Speaker Emory UniversityUnited States
  • The Need for a Structured POCUS Program for the Nephrology Trainee
    EduardoArgaiz Speaker Instituto Nacional de Ciencias Médicas y NutriciónMexico
  • How to Set Up an Interventional Nephrology Service With Limited Resources
    MayuriTrivedi Speaker India
  • Q&A
Neelkamal Hall 305
LilyMushahar Chair lilymushahar@gmail.comLily Mushahar, Hospital Tuanku Ja'afar Seremban, MalaysiaMalaysia
Sudarshan BallalBallal Chair s.ballal@manipalhospitals.comIndia
  • How Do I…Get Pregnant With Kidney Disease?
    SilviShah Speaker University of Cincinnati, Ohio, United StatesUnited States
  • How Do I…Manage Kidney Transplant Recipients Who Are Losing Their Graft?
    SunitaBavanandan Speaker Hospital Kuala Lumpur, MalaysiaMalaysia
  • How Do I…Set Up and Implement Multidisciplinary Kidney Care?
    IfeomaUlasi Speaker College of Medicine, University of NigeriaNigeria
  • How Do I…Conduct Immune Risk Stratification of Potential Kidney Transplant Recipients?
    AjayKher Speaker Epitome Kidney Urology InstituteIndia
  • How Do I…Design and Implement Large Simple Trials?
    MegJardine Speaker NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
  • Q&A
Parijat Hall 201
4:15 p.m.
5:15 p.m.
AminuBello Chair aminu1@ualberta.caUniversity of AlbertaCanada
HarunUr Rashid Chair Kidney Foundation Hospital and Research InstituteBangladesh
  • Hot Debate - We Should Have Universal Screening For CKD: ISN-ERA Special Lecture - PRO
    AlbertoOrtiz Speaker IIS-Fundacion Jimenez Diaz UAM, Madrid, SpainSpain
  • Hot Debate - We Should Have Universal Screening For CKD: ISN-ERA Special Lecture - CON
    GermaineWong Speaker University of SydneyAustralia
Amaltas A Hall B101A
ShrutiTapiawala Chair shruti16374@gmail.comGleneagles Hospital Mumbai , Sir HN Reliance Foundation Hospital and Research Center, MumbaiIndia
  • Anti-nephrin Antibodies - What Do We Know and What Can We Look Forward to?
    TobiasHuber Speaker University Medical Center Hamburg-EppendorfGermany
  • Mechanism of IgA Deposition in the Mesangium: Implication for Novel Treatments
    Yoshihito Nihei Speaker Department of Nephrology, Juntendo University Faculty of MedicineJapan
  • Lupus Nephritis: Recent Advances in Pathogenesis and New Therapeutic Approaches
    Prof LizLightstone Speaker Imperial College LondonUnited Kingdom
  • Q&A
Auditorium Brahmkamal Hall
  • Hot Debate: In This New Era of Artificial Intelligence, We No Longer Need Renal Pathologists - PRO
    KimSolez Speaker
  • Hot Debate: In This New Era of Artificial Intelligence, We No Longer Need Renal Pathologists - CON
    AgnesFogo Speaker United States
Champa Hall 304
DominiqueMartin Chair Deakin UniversityAustralia
MadhukarMisra Chair misram@health.missouri.eduUnited State
  • Introduction: the Difficulty of Translating Ethical Ideals in the Real World
    DominiqueMartin Speaker Deakin UniversityAustralia
  • Case Study 1: The Disruptive Dialysis Patient
    IanDittmer Speaker
  • Case Study 2: The Dodgy Doctor
    PriyaPais Speaker
  • Case Study 3: The Insistent Family
    GhadaAnkawi Speaker King Abdulaziz University Saudi Arabia
  • Q and A, and Conclusion: Ethical Recommendations for Real World Practice
Gulmohar Hall 302
AmitGovil Chair amit.govil@uc.eduUnited States
S AnanthKarumanchi Chair SAnanth.Karumanchi@csmc.eduUnited States
  • The Complement System in C3G and IgAN: A Pathophysiologic Perspective
    HernánTrimarchi Speaker HOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
  • The Complement System in C3G: Updated Therapeutic Approaches
    DavidKavanagh Speaker National Renal Complement Therapeutics Centre United Kingdom
  • The Complement System in IgAN: An Updated Therapeutic Approach
    HeatherReich Speaker University of Toronto, University Health NetworkCanada
  • Q&A
Kumudini Hall 301
  • Primary Kidney Disease Prevention: The 8 Golden Rules
    DinaAbdellatif Speaker Cairo University HospitalEgypt
  • Proactive Kidney Health: The Return on Investment of Early Detection
    JosephVassalotti Speaker Icahn School of Medicine at Mount SinaiUnited States
  • Kidney Health Across Ages: Comparing Risk Factors in Adults and Pediatrics
    AnnaFrancis Speaker University of QueenslandAustralia
  • Kidney Awareness: Engaging Patients for Better Outcomes
  • Q&A
Neelkamal Hall 305

Saturday, February 8, 2025

Time Session
8:30 a.m.
9:30 a.m.
Industry Symposium
Amaltas A Hall B101A
Industry Symposium
Champa Hall 304
Meet the Experts
Kesar Hall 202
Industry Symposium
Neelkamal Hall 305
9:45 a.m.
11:15 a.m.
Hyeong CheonPark Chair amp97nody@gmail.comHyeong Cheon Park, Gangnam Severance Hospital, Yonsei UniversityKorea (Republic of)
  • What Do We Know About the Association Between AKI and Long-Term Adverse Outcomes?
    Chi-yuanHsu Speaker University of California, San FranciscoUnited States
  • Are Biomarkers in AKI Ready for Prime Time?
    ChiragParikh Speaker Johns Hopkins University
  • Community-acquired AKI in the Tropics - Is it a Different Disease?
    VivekKumar Speaker Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaIndia
  • Sex as a Biological Variable in the Epidemiology of AKI
    MarliesOstermann Speaker King's College LondonUnited Kingdom
  • Q&A
Amaltas A Hall B101A
DineshKhullar Chair drdineshkhullar@gmail.comIndia
Fatiu AbiolaArogundade Chair fatiu3@yahoo.comObafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria Nigeria
MayuriTrivedi Chair India
  • Guideline-based Treatment of Anaemia of CKD: What's New?
    Kai-UweEckardt Speaker Department of Nephrology and Medical Intensive CarGermany
  • HIF-PHIs: Two Sides of the Same Coin
    Chuan-MingHao Speaker Fudan University Huashan HospitalChina
  • Iron Therapy in CKD: Moving Targets
    EviNagler Speaker Nephrology Department, Ghent University Hospital, Belgium
  • Consequences of Iron Overload
    RobertKalyesubula Speaker Makerere, UniversityUganda
  • Q&A
Amaltas B Hall B101A
SanjayPandya Chair saveyourkidney@gmail.comIndia
  • Revisiting Kidney Biopsies: Why More Than One Can Be Beneficial
    BradRovin Speaker The Ohio State UniversityUnited States
  • Genetic Testing for Kidney Disease Is Not Complicated
    KelsieBogyo Speaker Columbia University Irving Medical CenterUnited States
  • Thrombotic Microangiopathy Workup: Everything You Need to Know
    AnujaJava Speaker WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUISUnited States
  • Dealing With Biological Variability in Albuminuria and Creatinine
    SusrutWaikar Speaker Boston University Chobanian and Avedisian School of Medicine, and Boston Medical CenterUnited States
  • The Underdiagnosis of Primary Aldosteronism in Clinical Practice
    VivekBhalla Speaker Director, Stanford Hypertension Center, AHA-Certified Comprehensive Hypertension CenterUnited States
  • Q&A
Auditorium Brahmkamal Hall
BradRovin Chair The Ohio State UniversityUnited States
GermaineWong Chair University of SydneyAustralia
PierreRonco Chair Hôpital TenonFrance
  • Kidney International in Focus: Annual Highlights
    PierreRonco Speaker Hôpital TenonFrance
  • ISN-KI Fellows: Showcasing Excellence Part 1
    Eugene Yu HinChan Speaker Hong Kong Children's Hospital, Hong KongHong Kong, China
  • ISN-KI Fellows: Showcasing Excellence Part 2
    IsabelleAyoub Speaker The Ohio State UniversityUnited States
  • ISN-KI Fellows: Showcasing Excellence Part 3
    ChristophKuppe Speaker Department of Nephrology, RWTH University Aachen, GermanyGermany
  • ISN-KI Fellows: Showcasing Excellence Part 4
    GriffithPerkins Speaker Australia
  • Q and A
  • Kidney International Reports in Focus: Annual Highlights
    JaiRadhakrishnan Speaker Columbia University in the City of New YorkUnited States
  • Kidney International Reports in Focus: Annual Highlights
    SumitMohan Speaker Columbia UniversityUnited States
  • Kidney International Reports in Focus: Annual Highlights
    AnnaFrancis Speaker University of QueenslandAustralia
  • Q and A
  • Celebrating Excellence: Best Reviewer Awards Presentation
    BradRovin Speaker The Ohio State UniversityUnited States
  • Recognizing the Best: Basic Science Awards for Early Career Researchers
    VeronicaMiguel Speaker Spanish National Centre for Cardiovascular ResearchSpain
  • Recognizing the Best: Clinical Science Awards for Early Career Researchers
    MuzamilHassan Speaker Department of Medicine, Obafemi Awolowo University, Ile-Ife, NigeriaNigeria
  • Recognizing the Best: ISN-KI Editorial Fellows Awards
    GermaineWong Speaker University of SydneyAustralia
Champa Hall 304
AdrianLiew Chair Mount Elizabeth Novena Hospital, SingaporeSingapore
AnuragGupta Chair dranuragg1@yahoo.comIndia
SimonDavies Chair simonj.davies55@gmail.comUnited Kingdom
  • Peritoneal Dialysis: A Global Epidemiological Perspective
    RajnishMehrotra Speaker University of WashingtonUnited States
  • What’s Stopping PD Use in South Asia?
    PritiMeena Speaker India
  • International Home Dialysis Consortium (IHDC) Initiatives: Expanding Global Access to Peritoneal Dialysis
    EdwinaBrown Speaker Imperial College Healthcare NHS TrustUnited Kingdom
  • Empowering Nurses to Support Growth of Peritoneal Dialysis Programs
    ReenaGeorge Speaker India
  • Q&A
Gulmohar Hall 302
ElenaZakharova Chair helena.zakharova@gmail.comElena Zakharova, Botkin Hospital, Moscow, RussiaRussia
  • Empowering Kidney Care Through Advocacy: Strategies and Success Stories
    LauraSola Speaker Dialysis Center, CASMU-IAMPP Uruguay
  • How to Convince Your Health Minister to Invest in CKD Prevention
    Elliot KorantengTannor Speaker Kwame Nkrumah University of Science and Technology, Kumasi, GhanaGhana
  • Toward Removal of Socioeconomic Inequities in Kidney Care and Better Outcomes for Children
    ArpanaIyengar Speaker ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALOREIndia
  • How Do We Advocate for Better Access to Kidney Transplantation Worldwide?
    IkechiOkpechi Speaker University of AlbertaCanada
  • Q&A
Kumudini Hall 301
ArvindConjeevaram Chair canchi8@gmail.comHead - Nephrology Dept, Trustwell Hospitals, Bangalore India
DebasishBanerjee Chair dbanerje@sgul.ac.ukSt George's University Hospital NHS Foundation TrUnited Kingdom
  • How Do I Treat Renal Complications in Patients With Sickle Cell Disease?
    ClaireSharpe Speaker University of Nottingham and King\'s College Hospital, LondonUnited Kingdom
  • iPSCs to Model Rare Kidney Diseases for Drug Discovery: The Examples of FSGS and ADPKD
    ArielaBenigni Speaker Mario Negri Institute for Pharmacological Research, ItalyItaly
  • Fabry's Disease: Clinical Features and Novel Therapeutics
  • Primary Hyperoxaluria: A Hope for Gene Therapy?
  • Q&A
Neelkamal Hall 305
  • TB in Transplant Candidates and Recipients: Diagnosis and Treatment
    Shyam BihariBansal Speaker India
  • Bringing in Personalized Medicine Approaches to Kidney Transplantation: What Is Possible
    Harbir SinghKohli Speaker Professor & Head of Nephrology, Post Graduate Institute of Medical Education & Research, Chandigarh, IndiaIndia
  • Kidney Transplantation in Children: What Are the Special Issues and How to Navigate Them?
    PriyaVerghese Speaker Professor, Division Chief
  • Bringing Equity to Transplantation: Barriers, Challenges and Triumphs
  • Q and A
Parijat Hall 201
11:45 a.m.
12:45 p.m.
  • Environmental Stressors and Adaptation Mechanisms: From Marine Organism to (Kidney) Health Care. Claude Amiel Lecture
    TamarLotan Speaker University of Haifa
  • Q and A
  • Acceptance Speech: Alfred Newton Richards Award
    ArielaBenigni Speaker Mario Negri Institute for Pharmacological Research, ItalyItaly
Auditorium Brahmkamal Hall
1 p.m.
2 p.m.
Industry Symposium
Amaltas A Hall B101A
Industry Symposium
Amaltas B Hall B101A
Industry Symposium
Champa Hall 304
Industry Symposium
Gulmohar Hall 302
Industry Symposium
Kumudini Hall 301
2:15 p.m.
3:45 p.m.
ValentineLobo Chair valentinelobo702@gmail.comIndia
  • Deciphering the Molecular Development of Kidney Disease: Transition From AKI to CKD
    SanjayJain Speaker
  • KidGen Consortium - Integrating Genomic Medicine Into Care
    AndrewMallett Speaker JCU & THHSAustralia
  • Metadata Ontology, Knowledge Integration, and Kidney Precision Medicine
    MatthiasKretzler Speaker University of MichiganUnited State
  • Kidney Health Professionals and AI - Pioneers or Passive Users?
    GirishNadkarni Speaker United States
  • Q&A
Amaltas A Hall B101A
Arpita Roychaudhuri Chair lahiri.arpi@gmail.comIndia
DibyaSingh Shah Chair dibyasingh@hotmail.comNepal
Lori-AnnFisher Chair lori2k15@gmail.comUniversity of the West Indies, MonaJamaica
  • Blood Pressure Management in Dialysis: Is it All Fluid?
    SandipMitra Speaker United Kingdom
  • What Is a Pragmatic Approach Toward Hemodiafiltration in a Resource-limited Setting?
    SandeepMahajan Speaker All India Institute of Medical Sciences Delhi India
  • What Adult Nephrologists Need to Know About Pediatric Dialysis
    RukshanaShroff Speaker MD, FRCPCH, PhDUnited Kingdom
  • PD in Heart Failure
    AliAbu-Alfa Speaker American University of Beirut and Yale UniversityLebanon
  • Q&A
Amaltas B Hall B101A
PierreRonco Chair Hôpital TenonFrance
RajkumarSharma Chair rksnepho206@gmail.comIndia
  • Glomerular Disease Diagnostics
    SanjeevSethi Speaker Mayo ClinicUnited States
  • Advances in Glomerular Disease Treatment
    JonathanBarratt Speaker University of Leicester, Leicester, UKUnited Kingdom
  • Evaluating Kidney Allograft Dysfunction
    SumitMohan Speaker Columbia UniversityUnited States
  • Prioritizing Patient-friendly Dialysis
    EdwinaBrown Speaker Imperial College Healthcare NHS TrustUnited Kingdom
  • Risk Prediction in AKI and CKD
    NavdeepTangri Speaker United States
  • Q&A
Auditorium Brahmkamal Hall
ManjushaYadla Chair manjuyadla@gmail.comIndia
Muhammad Rafiqul Alam Chair alammrdr@gmail.comBangladesh
  • Acute Respiratory Distress Syndrome and the Kidney
  • Drug Treatment for Pulmonary Fibrosis: Implications for Kidney Fibrosis
  • Managing Pulmonary Renal Syndromes - What Do the Guidelines Say?
    VladimirTesar Speaker Charles University, PragueCzech Republic
  • Pulmonary Infections and Kidney Injury in ICUs
    RolandoClaure Del Granado Speaker Division of Nephrology, Hospital Obrero No 2 - Caja Nacional de Salud, Cochabamba Bolivia
  • Q&A
Champa Hall 304
RashaDarwish Chair Kasr Aleiny medical school , Cairo UniversityEgypt
UrmilaAnandh Chair uanandh@gmail.comAmrita Hospitals, Faridabad, Delhi NCRIndia
  • Patient Presentation
  • Pregnancy-related AKI – a Lethal Problem
    DIVYABAJPAI Speaker India
  • aHUS in Pregnancy - What Do We Know and What Can We Do?
    AnujaJava Speaker WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUISUnited States
  • Using Pregnancy to Initiate Long-term Kidney Care for Women
    SaraladeviNaicker Speaker University of the Witwatersrand South Africa
  • Developmental Origins of Kidney Disease: It’s All About Mother
    KateBramham Speaker King's College LondonUnited Kingdom
  • Panel Discussion with Speakers: How to Change Things? How to Raise Awareness?
Gulmohar Hall 302
BradRovin Chair The Ohio State UniversityUnited States
GermaineWong Chair University of SydneyAustralia
PierreRonco Chair Hôpital TenonFrance
  • Introduction
    PierreRonco Speaker Hôpital TenonFrance
  • Translational Science/Genomics
    ChristophKuppe Speaker Department of Nephrology, RWTH University Aachen, GermanyGermany
    KrzysztofKiryluk Speaker Columbia UniversityUnited States
  • Discovery Science
    ReikoInagi Speaker The University of Tokyo Graduate School of MedicineJapan
    VeronicaMiguel Speaker Spanish National Centre for Cardiovascular ResearchSpain
  • Clinical Trials
    BradRovin Speaker The Ohio State UniversityUnited States
  • Crossing the Lines to ‘Acceptance’ in High Impact Kidney Journals
    PierreRonco Speaker Hôpital TenonFrance
    SumitMohan Speaker Columbia UniversityUnited States
  • Epidemiology/Stats/Policy Forum
    AnnaFrancis Speaker University of QueenslandAustralia
    GermaineWong Speaker University of SydneyAustralia
    MuzamilHassan Speaker Department of Medicine, Obafemi Awolowo University, Ile-Ife, NigeriaNigeria
Kesar Hall 202
AakashShingada Chair aakashshingada@gmail.comIndia
KornchanokVareesangthip Chair kornchanok.ploy@gmail.comSiriraj Hospital, Mahidol University, ThailandThailand
MarinaWainstein Chair marinawainstein@outlook.comUniversity of QueenslandAustralia
  • Next-Gen Perspectives Debate: Will AI Replace Nephrologists in the Future?
    AlejandroGarcia-Rivera Speaker Hospital General Regional 46Mexico
    IntissarHaddiya Speaker Morocco
    Jean-PhilippeBertocchio Speaker SKEZI (France) & Assistance Publique-Hôpitaux de Paris (France)
    Kyung DonYoo Speaker Ulsan University Hospital, University of Ulsan College of Medicine / Deputy Director, Disaster Preparedness and Response Committee, The Korean Society of Nephrology Korea (Republic of)
Kumudini Hall 301
DominiqueMartin Chair Deakin UniversityAustralia
TobyCoates Chair toby.coates@sa.gov.auAustralia
  • Reviewing Transplantation in Tanzania: Barriers to Expansion and Insights for Other African Countries
    FransiaMushi Speaker Muhimbili University of Health and Allied SciencesTanzania
  • The Role of Infectious Disease Expertise in Improving Utilization and Preserving Grafts
    JonathanHand Speaker Ochsner HealthUnited States
  • Day-to-Day Challenges in Providing Kidney Replacement Therapy for Women in Low-income Countries
    PritiMeena Speaker India
  • Transplantation in Thailand: In-depth Review of Current Activities and Progress
    AdisornLumpaopong Speaker Pediatric Nephrology Consultant, Division of Pediatric Nephrology, Department of Pediatrics, Phramongkutklao Hospital Thailand
  • Q&A
Neelkamal Hall 305
AdeeraLevin Chair Canada
AndreaViecelli Chair andrea.viecelli@health.qld.gov.auUniversity of QueenslandAustralia
Ajit singhNarula Chair narulaas@gmail.comIndia
  • Novel Trial Designs in Nephrology: Innovations and Structures
    MegJardine Speaker NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
  • What’s New in Clinical Trials?
    DavidWheeler Speaker University College LondonUnited Kingdom
  • Value of Different Outcomes in the Era of Precision Medicine
    RobertoPecoits Filho Speaker Arbor Research Collaborative for HealthUnited States
  • Conducting Trials in Low and Middle-income Countries
    SoumitaBagchi Speaker India
  • Innovations in Pediatric Nephrology Discovery and Clinical Trial Conduct
    ArpanaIyengar Speaker ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALOREIndia
  • Q&A
Parijat Hall 201
4:15 p.m.
5:15 p.m.
FergusCaskey Chair University of Bristol, UKUnited Kingdom
OMKUMAR Chair dromkumar@rediffmail.comINDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES, PATNAIndia
UmeshKhanna Chair ubkhanna@gmail.com MD DNB (NEPHROLOGY), India
  • Hot Debate: To D or Not to D? All Patients With CKD Need Vitamin D Supplementation - PRO
    HanneJoergensen Speaker Aarhus UniversityDenmark
  • Hot Debate: To D or Not to D? All Patients With CKD Need Vitamin D Supplementation - CON
    Mario GennaroCozzolino Speaker University of MilanItaly
Amaltas B Hall B101A
ArpanaIyengar Chair ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALOREIndia
KateBramham Chair King's College LondonUnited Kingdom
Venkata DakshinamurtyKaligotla Chair kvdm1954@gmail.comMahatma Sri Ramchandra Centenary Memorial Hospital, Vijayanagar Colony, Hyderabad, INDIAIndia
  • Hot Debate: The KDIGO BP Targets in CKD Are Unachievable and Unrealistic - PRO
    SwapnilHiremath Speaker University of OttawaCanada
  • Hot Debate: The KDIGO BP Targets in CKD Are Unachievable and Unrealistic - CON
    IndranilDasgupta Speaker Consultant Nephrologist, University Hospitals Birmingham, UK
Auditorium Brahmkamal Hall
RobertoPecoits Filho Chair Arbor Research Collaborative for HealthUnited States
  • A Nephrologist Perspective on the Cardio-Kidney-Metabolic Syndrome
    JananiRangaswami Speaker Professor of Medicine, George Washington University School of MedicineUnited States
  • Optimizing CKD Management in the Context of Diabetes and Obesity
    RobertoPecoits Filho Speaker Arbor Research Collaborative for HealthUnited States
  • Combining Therapies for Cardio-Kidney-Metabolic Conditions: An Integrative Approach
    KatherineTuttle Speaker University of Washington School of Medicine, Division of NephrologyUnited States
  • Q&A
Champa Hall 304
LarisaPrikhodina Chair LPrikhodina@yahoo.comProfessor of Pediatrics, Chair of Division of Inherited & Acquired Kidney Diseases, Veltishev Research Clinical Institute for Pediatrics & Children Surgery, Pirogov Russian National Research Medical UniversityRussia
NeveenSoliman Chair Center of Pediatric Nephrology and Transplantation, Kasr Al Ainy Faculty of Medicine, Cairo UniversityEgypt
TarunJeloka Chair tjeloka@yahoo.comMANIPAL HOSPITALSIndia
  • Mapping Nephrogenomic Variation in the Middle East
    NeveenSoliman Speaker Center of Pediatric Nephrology and Transplantation, Kasr Al Ainy Faculty of Medicine, Cairo UniversityEgypt
  • Implementing Nephrogenetic Diagnostics in Low-resource Settings
    Kar HuiNg Speaker Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore
  • Comprehensive Nephrogenetic Diagnostics in Europe: Where Do We Stand in 2025?
    AlbertienVan Eerde Speaker Department of Genetics, UMC Utrecht, The NetherlandsNetherlands
  • Q and A
Gulmohar Hall 302
MegJardine Chair NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
  • Addressing Challenges: Early CKD Detection Strategies and the Role of Research and Development in Global Kidney Health
    AdeeraLevin Speaker Canada
  • A Collaborative Approach to Detecting Kidney Disease Early
    ThomasBlakeman Speaker United Kingdom
  • Harnessing Digital Technology: Innovative Tools for Early CKD Detection and Management
    Chinta RamaKrishna Speaker Chinta Rama Krishna, HelloKidney.aiIndia
  • Q and A
Kesar Hall 202
SabineKaram Chair sabinejkaram@gmail.comUniversity of MinnesotaUnited States
  • Managing Kidney Disease in Diabetes - Is it the Best of Times?
    PeterRossing Speaker Steno Diabetes Center Copenhagen Denmark
  • Implementation of Risk Prediction Equations to Optimize CKD Care - the Present and the Future
    NavdeepTangri Speaker United States
  • Multisectoral Action for Kidney Disease Prevention
    Sri LekhaTummalapalli Speaker United States
  • Q&A
Kumudini Hall 301
KamalSud Chair kamal.sud@health.nsw.gov.auThe University of SydneyAustralia
SanjayNagral Chair sanjaynagral@gmail.comIndia
  • My Patient Wants to Travel Abroad for a Kidney Transplant
    JagbirGill Speaker Canada
  • My Patient Received a Kidney Transplant Abroad
    RuthRahamimov Speaker Rabin Medical Center, Petach Tikva, IsraelIsrael
  • How to Deal With Suspicious Transplant Cases in Your Organization or Country
    JonathanWala Speaker Kenya Renal AssociationKenya
  • From Identification to Resolution: A Guide to Managing Suspicious Transplant Cases
    ThomasMueller Speaker Switzerland
  • Q&A
Neelkamal Hall 305
DanielO'Hara Chair daniel.ohara@sydney.edu.auAustralia
MythriShankar Chair Institute of NephrourologyIndia
  • Panel Discussion: Featuring an Expert in Genetics
    Becky MingyaoMa Speaker Division of Nephrology, Department of Medicine, School of Clinical Medicine, University of Hong KongHong Kong, China
  • Panel Discussion: Featuring a Renal Pathologist
    MarekKollar Speaker Czech Republic
  • Panel Discussion: Featuring an Expert in CKD Care From India
    PritiMeena Speaker India
  • Panel Discussion:Featuring an Expert in CKD Care From Fiji
    Yogeshni Chandra Speaker Fiji
  • Panel Discussion: Featuring an Expert in CKD Care From Nigeria
    ChimezieOkwuonu Speaker Nigeria
  • Q and A
Parijat Hall 201

Sunday, February 9, 2025

Time Session
9:45 a.m.
11:15 a.m.
GloriaAshuntantang Chair gloria.ash60@gmail.comUniversity of Bamenda, CameroonCameroon
Dr Sree BhushanRaju Chair sreebhushan@hotmail.comIndia
  • Hepatorenal Syndrome and New Treatments for AKI in Cirrhosis
    Swetha RaniKanduri Speaker Ochsner Health, New Orleans, LA
  • Do Gut Microbiota Contribute to Kidney Disease? If so, What Can We Do About it?
    GrietGlorieux Speaker UGentBelgium
  • What Should Nephrologists Know About Metabolic Dysfunction-associated Fatty Liver Disease
    Angela Yee-MoonWang Speaker Hong Kong/SingaporeSingapore
  • Measuring Kidney Function in Liver Disease - Pitfalls and Solutions
    SmitaDivyaveer Speaker India
  • Q&A
Amaltas A Hall B101A
AnupmaKaul Chair anupmaneph@gmail.comIndia
Mohamad Bassam Said Chair bmsaeed2000@yahoo.com Farah Association for Child with Kidney Disease in SyriaSyrian Arab Republic
  • Defining Accelerated Kidney Ageing
  • Accelerated Biological Ageing in CKD: Drivers and Potential Therapeutic Interventions
    MotokoYanagita Speaker Kyoto UniversityJapan
  • The Kidney-Brain Connection
    MarionPépin Speaker INSERM, CESP UMR 1018, Clinical epidemiology, Paris Saclay University, Villejuif, France/ Geriatric Department, Ambroise Paré Hospital, APHP, Versailles St Quentin University, Boulogne ,FranceFrance
  • Cognitive Impairment in Kidney Disease
    VanitaJassal Speaker
  • Q&A
Amaltas B Hall B101A
DavidWheeler Chair University College LondonUnited Kingdom
  • What Have We Learned From CONVINCE?
  • Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease
    VladoPerkovic Oral Abstract Presenter vlado.perkovic@unsw.edu.auUniversity of New South Wales, Sydney, AustraliaAustralia
  • A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
    JonathanBarratt Oral Abstract Presenter University of Leicester, Leicester, UKUnited Kingdom
  • Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease
    PriscillaSmith Oral Abstract Presenter priscilla.smith@kcl.ac.ukKings College Hospital LondonUnited Kingdom
  • Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage
    Selvin Sundar RajMani Oral Abstract Presenter selvinsr@gmail.comIndia
    SuceenaAlexander Oral Abstract Presenter Christian Medical College VelloreIndia
Auditorium Brahmkamal Hall
ManjuriSharma Chair manjurisharma@yahoo.com India
  • Toward a Plant-based Diet in CKD
  • Why Peritoneal Dialysis Uptake Is Low in Many World Regions and How Can We Fix it?
    Magdalena Madero Speaker Chief of Nephrology, Instituto Nacional de CardiolMexico
  • Improving Dialysis Quality: A Hub-and-Spoke Network
    Osmaniahospital Speaker India
  • Kidney Supportive Care in a Low-resource Setting
    NicolaWearne Speaker Groote Schuur Hospital / university of Cape TownSouth Africa
  • A Working Partnership - Shared Decision-making in Nephrology
    ANAFIGUEIREDO Speaker Pontifícia Universidade Católica do Rio Grande do Brazil
  • Q&A
Neelkamal Hall 305
11:45 a.m.
12:45 p.m.
  • Diabetes and Adipocytokines. Brenner/Dirks Lecture
    TakashiKadowaki Speaker Toranomon Hospital
  • Q and A
  • The ISN Fellowship Program Celebration
Auditorium Brahmkamal Hall

Thursday, February 6, 2025

Time Session
9 a.m.
11 a.m.
AndrewMoses Chair Lenox Hill Hospital, Northwell HealthUnited States
IrmaTchokhonelidze Chair Georgia
JadrankaButurović Ponikvar Chair University Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, SloveniaSlovenia
MayuriTrivedi Chair India
SourabhSharma Chair Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, IndiaIndia
  • Case Study Part 1 and POCUS Kidney and Lungs BLUE Protocol
    AndrewMoses Speaker Lenox Hill Hospital, Northwell HealthUnited States
  • Native and Transplanted Kidney Biopsy
    JadrankaButurović Ponikvar Speaker University Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, SloveniaSlovenia
    MayuriTrivedi Speaker India
  • CKRT vs. SLED: Pros and Cons
    SourabhSharma Speaker Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, IndiaIndia
  • Hands-on Training: Kidney Biopsy
    JadrankaButurović Ponikvar Speaker University Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, SloveniaSlovenia
    MayuriTrivedi Speaker India
  • Hands-on Training: CKRT and SLED Machine
    SourabhSharma Speaker Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, IndiaIndia
  • Hands-on Training: POCUS Kidney and Lung With BLUE Protocol
    AndrewMoses Speaker Lenox Hill Hospital, Northwell HealthUnited States
    HildaElena Fernandez Speaker United States
Amaltas A Hall B101A
CarmenAvila Casado Chair Canada
GeetikaSingh Chair All India Institute of Medical Sciences, New Delhi, India India
SuryaSeshan Chair Weill Cornell MedicineUnited States
  • IgA Nephropathy and IgA Vasculitis
    MarkHaas Speaker United States
  • Kidney Lesions in Tropical Infections
    AhmedKalebi Speaker Dr. Kalebi Labs (DKL) LimitedKenya
  • Controversies in Podocytopathies
    CarmenAvila Casado Speaker Canada
  • Pregnancy Related Renal Disease
    AgnesFogo Speaker United States
  • Q and A
Amaltas B Hall B101A
ANAFIGUEIREDO Chair Pontifícia Universidade Católica do Rio Grande do Brazil
ReenaGeorge Chair India
  • Navigating Post-transplant Dialysis: What to Expect
    AngelaJackson Speaker New Zealand
  • From Dialysis to Transplant: Guiding Children Through the Transition
    Sandhya VNair Speaker indian nursing councilIndia
  • Meeting the Mark: Adherence Requirements for Transplant Success
    Janevan der Jeugd Speaker Flinders Medical Centre, Adelaide, South AustraliaAustralia
  • Q&A
Champa Hall 304
AdrianLiew Chair Mount Elizabeth Novena Hospital, SingaporeSingapore
SuceenaAlexander Chair Christian Medical College VelloreIndia
  • Approach to Nephrotic Syndrome
    SuceenaAlexander Speaker Christian Medical College VelloreIndia
  • Case Presentation and Discussion 1
    HeatherReich Speaker University of Toronto, University Health NetworkCanada
  • Case Presentation and Discussion 2
    Raja Ramachandran Speaker Associate ProfessorIndia
Gulmohar Hall 302
FrankBrennan Chair St George HospitalAustralia
SaraDavison Chair University of AlbertaCanada
  • Introduction to Kidney Supportive Care (KSC) and Conservative Kidney Management (CKM)
    SaraDavison Speaker University of AlbertaCanada
  • Validating CKM: Evidence and Approaches
    BarnabyHole Speaker United Kingdom
  • Effective Strategies for Pharmacologic Pain Management in CKM
    SaraDavison Speaker University of AlbertaCanada
  • Addressing Depression and Anxiety in CKM Patients
    PeaceBagasha Speaker Uganda
  • Q&A
Kumudini Hall 301
KenarJhaveri Chair United States
Osmaniahospital Chair India
MitchellRosner Chair Univeristy of Virginia HealthUnited States
  • New Solutions to Anemia Management in Kidney Failure: The Role of HIF-PH Inhibitors
    JolantaMalyszko Speaker Medical University of Warsaw, PolandPoland
  • Test
    ShiraStrachova Speaker sstrachova@Theisn.orgISNBelgium
  • New Solutions to Phosphorus Control in Kidney Failure: Achieving Patient Goals
    KrishnaswamySampathkumar Speaker Meenakshi Mission Hospital India
  • Improving Volume and Hypertension Control in Kidney Failure: New Approaches to a Critical Issue?
    Angela Yee-MoonWang Speaker Hong Kong/SingaporeSingapore
  • Q and A
Neelkamal Hall 305
11:30 a.m.
1:30 p.m.
AndrewMoses Chair Lenox Hill Hospital, Northwell HealthUnited States
IrmaTchokhonelidze Chair Georgia
JadrankaButurović Ponikvar Chair University Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, SloveniaSlovenia
MayuriTrivedi Chair India
SourabhSharma Chair Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, IndiaIndia
  • Case Study Part 2 and Cardiac POCUS
    AndrewMoses Speaker Lenox Hill Hospital, Northwell HealthUnited States
  • Dialysis Adequacy: Assessing and Improving Outcomes
    IrmaTchokhonelidze Speaker Georgia
  • Hemodialysis Catheter: Insertion, Exchange, Removal
    AnilAGARWAL Speaker University of California San Francisco, Fresno, USUnited States
  • Hands-on Training: HD Catheters: Insertion, Exchange, Removal
    AnilAGARWAL Speaker University of California San Francisco, Fresno, USUnited States
    JeyarajBalasubramaniam Speaker Kidney Care Centre, Tirunelveli, IndiaIndia
  • Hands-on Training: HD/HDF/Home HD Machines: What are the Treatment Options?
    IrmaTchokhonelidze Speaker Georgia
  • Hands-on Training: Cardiac POCUS
    AndrewMoses Speaker Lenox Hill Hospital, Northwell HealthUnited States
    HildaElena Fernandez Speaker United States
Amaltas A Hall B101A
CarmenAvila Casado Chair Canada
GeetikaSingh Chair All India Institute of Medical Sciences, New Delhi, India India
SuryaSeshan Chair Weill Cornell MedicineUnited States
  • Mass Spectrometry for the Diagnosis of Renal Diseases
    SanjeevSethi Speaker Mayo ClinicUnited States
  • Application of Digital Tools in Renal Pathology
    ArvydasLaurinavicius Speaker Vilnius UniversityLithuania
  • The Importance of Medullary Lesions In Kidney Biopsies
    JorisRoelofs Speaker Amsterdam UMCNetherlands
  • New Insights in Drug Induced Kidney Diseases
    SuryaSeshan Speaker Weill Cornell MedicineUnited States
  • Q and A
Amaltas B Hall B101A
ANAFIGUEIREDO Chair Pontifícia Universidade Católica do Rio Grande do Brazil
ReenaGeorge Chair India
  • Enhancing Acute Care: Managing Late Referral Hemodialysis
    ANAFIGUEIREDO Speaker Pontifícia Universidade Católica do Rio Grande do Brazil
  • Enhancing Acute Care: Managing Urgent Start Peritoneal Dialysis
    ElaineBowes Speaker King's College Hospital United Kingdom
  • From Diabetes to Dialysis: Ensuring Smooth Care Transitions
    EveNatusch Speaker New Zealand
  • Better Together: Community Approaches to Preventing Chronic Kidney Disease
    SulakshnaBharadwaj Speaker INSTITUTE OF LIVER AND BILIARY SCIENCESIndia
  • Q&A
Champa Hall 304
AdrianLiew Chair Mount Elizabeth Novena Hospital, SingaporeSingapore
SuceenaAlexander Chair Christian Medical College VelloreIndia
  • Approach to Nephritic Syndrome
    AdrianLiew Speaker Mount Elizabeth Novena Hospital, SingaporeSingapore
  • Case Presentation and Discussion 3
    JonathanBarratt Speaker University of Leicester, Leicester, UKUnited Kingdom
  • Case Presentation and Discussion 4
    Prof LizLightstone Speaker Imperial College LondonUnited Kingdom
  • Case Presentation and Discussion 5
    SuceenaAlexander Speaker Christian Medical College VelloreIndia
Gulmohar Hall 302
FrankBrennan Chair St George HospitalAustralia
SaraDavison Chair University of AlbertaCanada
  • Managing CKD-associated Pruritus and Restless Legs Syndrome in CKM
    FrankBrennan Speaker St George HospitalAustralia
  • Tackling Fatigue and Insomnia in CKM Patients
    AnujaDamani Speaker Kasturba Medical College, Manipal, Manipal Academy of Higher Education, ManipalIndia
  • Managing Nausea and Vomiting in CKM: Best Practices
    ClaireDouglas Speaker
  • End-of-Life Transition in CKM: Care and Symptom Management
    NandiniVallath Speaker
  • Managing Metabolic Complications of CKD in CKM
    SaraDavison Speaker University of AlbertaCanada
  • Q&A
Kumudini Hall 301
KenarJhaveri Chair United States
Osmaniahospital Chair India
MitchellRosner Chair Univeristy of Virginia HealthUnited States
  • Clinical Trials Overview: Focus on GLP1a, MRA, and SGLT2
    MaartenTaal Speaker University of NottinghamUnited Kingdom
  • SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach
    KatherineTuttle Speaker University of Washington School of Medicine, Division of NephrologyUnited States
  • SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach
  • Q and A
Neelkamal Hall 305
1 p.m.
2:25 p.m.
ErangaWijewickrama Chair Faculty of Medicine, University of ColomboSri Lanka
  • Study Designs to Answer Research Questions in CKDu
    Magdalena Madero Speaker Chief of Nephrology, Instituto Nacional de CardiolMexico
  • Distinguishing CKDu From Other Kidney Diseases in Research Studies
    SumitMohan Speaker Columbia UniversityUnited States
  • Q and A
Javakusum Hall 303
FergusCaskey Chair University of Bristol, UKUnited Kingdom
MariaPippias Chair University of BristolUnited Kingdom
  • The SharE-RR Toolkit
    MariaPippias Speaker University of BristolUnited Kingdom
  • The Sri Lankan Renal Registry: Lessons from Intensive Care to HD to PD to CKD
  • The Bangladesh Renal Registry: Twenty Years Experience Covering HD, PD, and Transplant
    HarunUr Rashid Speaker Kidney Foundation Hospital and Research InstituteBangladesh
  • The Indian Renal Registry: Establishing a Multi-centre Dialysis Registry
    SumaiyaArfin Speaker India
  • Q and A
Kesar Hall 202
MichelleHladunewich Chair Canada
ShilpanjaliJesudason Chair Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
  • Welcome and Background on Obstetric Nephrology Evolution
    MichelleHladunewich Speaker Canada
  • Overview of the TT Program and Toolkit Launch
    ShilpanjaliJesudason Speaker Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
  • Trainer Perspective
    GhadaAnkawi Speaker King Abdulaziz University Saudi Arabia
  • Trainer Perspective
    DIVYABAJPAI Speaker India
  • Panel Discussion, Questions and Group Discussion
Mogra Hall A 404
2:15 p.m.
4:15 p.m.
AndrewMoses Chair Lenox Hill Hospital, Northwell HealthUnited States
IrmaTchokhonelidze Chair Georgia
JadrankaButurović Ponikvar Chair University Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, SloveniaSlovenia
MayuriTrivedi Chair India
SourabhSharma Chair Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, IndiaIndia
  • Case Study Part 3 and VExUS Technique
    AndrewMoses Speaker Lenox Hill Hospital, Northwell HealthUnited States
  • PD Catheter Insertion
    KrishnaswamySampathkumar Speaker Meenakshi Mission Hospital India
  • Urgent Initiation of PD: Challenges and Solutions
    BrettCullis Speaker South Africa
  • Hands-on Training: APD Machine Prescription Options
    BrettCullis Speaker South Africa
    IrmaTchokhonelidze Speaker Georgia
  • Hands-on Training: PD Catheter Insertion
    KrishnaswamySampathkumar Speaker Meenakshi Mission Hospital India
  • Hands-on Training: VExUS
    AndrewMoses Speaker Lenox Hill Hospital, Northwell HealthUnited States
    HildaElena Fernandez Speaker United States
  • Case 3
Amaltas A Hall B101A
CarmenAvila Casado Chair Canada
GeetikaSingh Chair All India Institute of Medical Sciences, New Delhi, India India
SuryaSeshan Chair Weill Cornell MedicineUnited States
Amaltas B Hall B101A
ANAFIGUEIREDO Chair Pontifícia Universidade Católica do Rio Grande do Brazil
ReenaGeorge Chair India
  • How Frail Is Too Frail? Addressing Frailty in Home Hemodialysis Patients
    RachaelWalker Speaker University of Auckland, New ZealandNew Zealand
  • Fostering Independence: Supporting Patients to Manage Home Dialysis AV-fistulas
    Fatimade Figueiredo Speaker United Kingdom
  • Mastering Nutrition: Optimal Diet for Managing Diabetic Kidney Disease
    GurdeepKaur Speaker India
  • Q&A
Champa Hall 304
AdrianLiew Chair Mount Elizabeth Novena Hospital, SingaporeSingapore
SuceenaAlexander Chair Christian Medical College VelloreIndia
  • Approach to Rapidly Progressive Glomerulonephritis
    Raja Ramachandran Speaker Associate ProfessorIndia
  • Case Presentation and Discussion 6
    HernánTrimarchi Speaker HOSPITAL BRITÁNICO DE BUENOS AIRESArgentina
  • Case Presentation and Discussion 7
    Muh GeotWong Speaker Australia
  • Case Presentation and Discussion 8
    AdrianLiew Speaker Mount Elizabeth Novena Hospital, SingaporeSingapore
Gulmohar Hall 302
FrankBrennan Chair St George HospitalAustralia
SaraDavison Chair University of AlbertaCanada
  • Shared Decision-making and Cultural Considerations in CKM
    SaharKoubar Speaker University of MinnesotaUnited States
  • Essential Communication Skills and Advance Care Planning in CKM (Interactive Workshop)
    AmarBansal Speaker University of Pittsburgh School of Medicine United States
  • Practical Challenges in Implementing CKM: Cultural and Resource Considerations From India
    NandiniVallath Speaker
  • Q&A
Kumudini Hall 301
KenarJhaveri Chair United States
Osmaniahospital Chair India
MitchellRosner Chair Univeristy of Virginia HealthUnited States
  • Approaches to the Patient with Severe Hyponatremia and Acute Kidney Injury
    MitchellRosner Speaker Univeristy of Virginia HealthUnited States
  • Approaches to Severe Hypercalcemia
    KenarJhaveri Speaker United States
  • Approaches to Severe Hyperkalemia
    KSNayak Speaker Virinchi HospitalsIndia
  • Q and A
Neelkamal Hall 305
  • Opening Remarks
  • Patient Testimony: Living with a Kidney Disease
    Kamal Shah Speaker NephroPlusIndia
  • Kidney Health in the Region: Trends, Challenges, and WHO Initiatives for Improved Care
Parijat Hall 201
2:35 p.m.
4 p.m.
ErangaWijewickrama Chair Faculty of Medicine, University of ColomboSri Lanka
  • What Should We Measure to Identify Disease in CKDu Research?
    BenCaplin Speaker University College LondonUnited Kingdom
  • How Can Kidney Biopsies Provide Causal Insight Into CKDu?
    ShuchiAnand Speaker
  • Q and A
Javakusum Hall 303
  • Introducing Local Voices
  • Advancing Kidney Health in India: A Strategic Overview of Current Challenges and Government Initiatives
  • Collective Action Towards Integrated Care: Learning from National NCD Program
    MonikaArora Speaker HRIDAYIndia
  • Kidney Health in India: Importance of Measurement, Quality Assurance, and Registries
  • Home Dialysis: Navigating Challenges and Opportunities
    Magdalena Madero Speaker Chief of Nephrology, Instituto Nacional de CardiolMexico
  • Q and A
Parijat Hall 201
2:45 p.m.
4:05 p.m.
MegJardine Chair NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
ShilpanjaliJesudason Chair Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
  • Using Registry Data in Trials: Lessons on Patient Reported Outcomes from SWIFT in Australia
    RachaelMorton Speaker NHMRC Clinical Trials Centre, The University of SydneyAustralia
  • Using Registry Data in Trials: Defining Measures of Kidney Function in Observational Studies Using Routine Health Care Data
  • Using Registry Data in Trials: Lessons from Tackling AKI, H4RT, and Prepare for Kidney Care in the UK
    FergusCaskey Speaker University of Bristol, UKUnited Kingdom
  • Q and A
Kesar Hall 202
3:20 p.m.
4:05 p.m.
UrmilaAnandh Chair uanandh@gmail.comAmrita Hospitals, Faridabad, Delhi NCRIndia
  • Introducing Voices from the Region
    UrmilaAnandh Chair uanandh@gmail.comAmrita Hospitals, Faridabad, Delhi NCRIndia
  • Kidney Health in the Region: Trends, Challenges, and WHO Initiatives for Improved Care
  • Leading the Way: Pioneering Universal Access to Dialysis in Thailand
    YotTeerawattananon Speaker HITAPThailand
  • The Role of Public-Private Partnerships in Dialysis Care and the Impact of Climate Change on Kidney Health in Bangladesh
    Kazi ShahnoorAlam Speaker Professor of Nephrology National Institute of Kidney Diseases and Urology, Dhaka, Bangladesh.Bangladesh
  • Myanmar: Community-Based Kidney Health Programs
  • Sri Lanka: Tackling the Socio-Economic Determinants of Chronic Kidney Disease of Unknown Etiology (CKDu)
  • Community-Based Screening through the Kidney Care Network in Nepal
    Sanjib KumarSharma Speaker Nepal
  • Q and A
Parijat Hall 201
4:05 p.m.
4:15 p.m.
  • Closing Remarks
  • Advancing Kidney Health: Insights from Patient Advocates
Parijat Hall 201
4:30 p.m.
6 p.m.
WCN'25 Opening Ceremony and Plenary Session 1
Auditorium Brahmkamal Hall